CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 3.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,161,626 | +4.5% | 19,963,157 | 0.0% | 41.24% | +19.1% |
| Q2 2023 | $123,571,942 | +60.8% | 19,963,157 | 0.0% | 34.62% | +5.1% |
| Q1 2023 | $76,858,154 | +24.2% | 19,963,157 | 0.0% | 32.93% | +26.7% |
| Q4 2022 | $61,885,786 | -22.9% | 19,963,157 | 0.0% | 25.99% | -22.2% |
| Q3 2022 | $80,252,000 | -58.7% | 19,963,157 | -50.0% | 33.41% | -17.3% |
| Q2 2022 | $194,442,000 | +8.6% | 39,926,314 | +100.0% | 40.37% | -16.8% |
| Q1 2022 | $179,070,000 | -12.3% | 19,963,157 | +10.1% | 48.51% | -5.0% |
| Q4 2021 | $204,075,000 | -31.8% | 18,123,892 | +1.1% | 51.07% | -21.6% |
| Q3 2021 | $299,329,000 | -24.8% | 17,923,892 | 0.0% | 65.12% | -8.7% |
| Q2 2021 | $398,090,000 | – | 17,923,892 | – | 71.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 3,931,818 | $31,297,271 | 37.26% |